The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1609
ISSUE1609
October 19, 2020
Lyumjev - A New Insulin Lispro for Diabetes
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Lyumjev - A New Insulin Lispro for Diabetes
October 19, 2020 (Issue: 1609)
The FDA has approved insulin lispro-aabc (Lyumjev –
Lilly), a faster-acting formulation of insulin lispro
(Humalog), for treatment of type 1 and type 2 diabetes
in adults. Fiasp, a faster-acting formulation of insulin
aspart (Novolog), was...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.